Results 131 to 140 of about 894,439 (381)
Determinants of Smoking Cessation: An Analysis of Young Adult Men and Women [PDF]
Substantial econometric efforts have been devoted to examining the impacts prices and tobacco control policies have on smoking propensity and intensity. However, little is known about the effects prices, smoking restrictions, and other influences have on
Frank J. Chaloupka, John A. Tauras
core
The Association of Socioeconomic and Environmental Factors with Smoking Cessation [PDF]
Background: Smoking cessation rates have remained stagnant globally. Environment factor plays an important role in the likelihood of achieving quitting from smoking.
Atmojo, J. T. (Joko ) +2 more
core
Background Smoking rates in the United States have been reduced in the past decades to 15% of the general population. However, up to 88% of people with psychiatric symptoms still smoke, leading to high rates of disease and mortality.
Roger Vilardaga +6 more
semanticscholar +1 more source
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang +3 more
wiley +1 more source
Effects of psychological conditions and changes on smoking cessation success after a residential smoking cessation therapy program: a retrospective observational study [PDF]
Background Residential smoking cessation therapy programs offer intensive treatment for heavy smokers who struggle to quit independently, particularly those with high nicotine dependence and health conditions that necessitate urgent cessation.
Gyu Lee Kim +10 more
doaj +1 more source
Barriers to Utilizing Medicaid Smoking Cessation Benefits [PDF]
Introduction. Smoking is the number one preventable cause of deathin the United States. Under the Affordable Care Act, Kansas Medicaidcovers all seven FDA-approved smoking cessation therapies.However, it is estimated only 3% of Kansas Medicaid smokers ...
Ellerbeck, Edward F. +5 more
core +2 more sources
Abstract Objective Status epilepticus (SE) is a neurological emergency requiring immediate treatment. Although intravenous lacosamide (LCM) is used for the management of epilepsy, its effectiveness in treating SE remains unclear. We aimed to compare the in‐hospital outcomes between intravenous LCM and levetiracetam (LEV) as an early adjunctive therapy ...
Yumiko Nakamura +8 more
wiley +1 more source
Smoking cessation activities by general practitioners and practice nurses [PDF]
OBJECTIVES—To assess general practitioners' and practice nurses' self reported behaviour, attitudes, and knowledge in relation to smoking cessation. DESIGN AND SETTING—Two postal surveys of random national samples of 303 GPs (survey 1) and 459 practice ...
McEwen, A, West, R
core +2 more sources
Background The landscape of smoking cessation may have changed in Europe recently. Objectives To identify changes in use of smoking cessation assistance in the European Union (EU) and factors associated with use of cessation assistance. Methods Data from
F. Filippidis +4 more
semanticscholar +1 more source

